All India Institute of Medical Sciences Director Randeep Guleria on June 27 reacted on surging COVID-19 cases in the country. He said that the rise in COVID cases in country are not that high if compared to countries affected from the invisible enemy and India has low mortality rate. He said, "Rise in cases in India is still not as high as compared to other countries. In US, there've been almost 40,000 cases per day in last 2 days, our numbers aren't that high. Cases per million population continue to be low and we still have low mortality rate."
The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria reacted over Delhi's Deputy Chief Minister Manish Sisodia's statement that 5.5 lakh cases are expected in the national capita by July 31. "Number of cases in Delhi may not be as high as predicted but still whatever be the number, we have to increase our capacity so that we can manage increasing load that healthcare system is going to get," he said.
Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe COVID-19 patients because of multiple drugs being used. Being asked about his opinion on WHO 'temporarily' suspending clinical trials of HCQ for COVID-19, Dr Guleria said, "There are 2 different aspects, using Hydroxychloroquine as part of treatment for severe COVID-19 patients has higher chance that you may have toxicity because of multiple drugs being used. And there are certain drugs which along with hydroxychloroquine can increase the chance of cardiac toxicity. On the other hand, when we are giving it as prophylaxis or in mild illness and giving it alone the chances of side effects are much less. We, as physicians have been using hydroxychloroquine for almost 30-40 years. Patients have been using it daily, not for week but for months and years with no side effects. So, when it is used judiciously, appropriately and not in combination with other drugs where the side effects can become much more, there is good suggestive data that suggests it is useful."
Central Armed Police Forces (CAPF) personnel who have recovered from coronavirus, donated plasma for treatment of COVID-19 positive patients. Speaking on it, Commandant 31st Battalion of CRPF, Deependra Rajput said, "139 CRPF jawans had tested positive for COVID-19 here. Out of 139, 138 have fully recovered and have returned to duty. Till now, three jawans have donated plasma and more are willing to do so. This is another way to serve the country." DIG of BSF, Lalit Kumar said, "We are preparing list of those who have recovered from COVID-19 and the list is with AIIMS hospital so whenever they'll feel need of plasma of BSF personnel, we will donate it to them."
Congress leader Rahul Gandhi interacted with nurses from 4 nations, including India, regarding the Covid-19 pandemic. In the virtual chat, Gandhi asked the nurses from India, Australia, New Zealand and..
Credit: HT Digital Content Duration: 06:10Published
Credit: World Health Organisation With more than 500,000 people dead and over 10 million confirmed Covid-19 cases worldwide, WHO director-general Tedros Adhanom Ghebreyesus has said this is "a moment..
Credit: PA - Press Association STUDIO Duration: 01:24Published